PROGNOSTIC BIOMARKERS IN ACTIVE SURVEILLANCE: PARSING RISK IN EARLY STAGE

$899,600FY2017Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →